109 related articles for article (PubMed ID: 16094422)
21. Lyl1 interacts with CREB1 and alters expression of CREB1 target genes.
San-Marina S; Han Y; Suarez Saiz F; Trus MR; Minden MD
Biochim Biophys Acta; 2008 Mar; 1783(3):503-17. PubMed ID: 18160048
[TBL] [Abstract][Full Text] [Related]
22. Lack of correlation between expression and function of P-glycoprotein in acute myeloid leukemia cell lines.
Bailly JD; Muller C; Jaffrézou JP; Demur C; Gassar G; Bordier C; Laurent G
Leukemia; 1995 May; 9(5):799-807. PubMed ID: 7769842
[TBL] [Abstract][Full Text] [Related]
23. Stage- and lineage-specific expression of the HOXA10 homeobox gene in normal and leukemic hematopoietic cells.
Lawrence HJ; Sauvageau G; Ahmadi N; Lopez AR; LeBeau MM; Link M; Humphries K; Largman C
Exp Hematol; 1995 Oct; 23(11):1160-6. PubMed ID: 7556525
[TBL] [Abstract][Full Text] [Related]
24. Retinoic acid induces signal transducer and activator of transcription (STAT) 1, STAT2, and p48 expression in myeloid leukemia cells and enhances their responsiveness to interferons.
Matikainen S; Ronni T; Lehtonen A; Sareneva T; Melén K; Nordling S; Levy DE; Julkunen I
Cell Growth Differ; 1997 Jun; 8(6):687-98. PubMed ID: 9186002
[TBL] [Abstract][Full Text] [Related]
25. The AML1 gene: a transcription factor involved in the pathogenesis of myeloid and lymphoid leukemias.
Lo Coco F; Pisegna S; Diverio D
Haematologica; 1997; 82(3):364-70. PubMed ID: 9234595
[TBL] [Abstract][Full Text] [Related]
26. Increased expression of AML1 during retinoic-acid-induced differentiation of U937 cells.
Tanaka K; Tanaka T; Ogawa S; Kurokawa M; Mitani K; Yazaki Y; Hirai H
Biochem Biophys Res Commun; 1995 Jun; 211(3):1023-30. PubMed ID: 7598688
[TBL] [Abstract][Full Text] [Related]
27. Molecular pathways mediating MDS/AML with focus on AML1/RUNX1 point mutations.
Harada Y; Harada H
J Cell Physiol; 2009 Jul; 220(1):16-20. PubMed ID: 19334039
[TBL] [Abstract][Full Text] [Related]
28. Combination of all-trans retinoic acid and lithium chloride surmounts a retinoid differentiation block induced by expression of Scl and Rbtn2 transcription factors in myeloid leukemia cells.
Rice AM; Li J; Sartorelli AC
Leuk Res; 2004 Apr; 28(4):399-403. PubMed ID: 15109540
[TBL] [Abstract][Full Text] [Related]
29. miR-10a overexpression is associated with NPM1 mutations and MDM4 downregulation in intermediate-risk acute myeloid leukemia.
Ovcharenko D; Stölzel F; Poitz D; Fierro F; Schaich M; Neubauer A; Kelnar K; Davison T; Müller-Tidow C; Thiede C; Bornhäuser M; Ehninger G; Brown D; Illmer T
Exp Hematol; 2011 Oct; 39(10):1030-1042.e7. PubMed ID: 21784052
[TBL] [Abstract][Full Text] [Related]
30. Physical interaction of the bHLH LYL1 protein and NF-kappaB1 p105.
Ferrier R; Nougarede R; Doucet S; Kahn-Perles B; Imbert J; Mathieu-Mahul D
Oncogene; 1999 Jan; 18(4):995-1005. PubMed ID: 10023675
[TBL] [Abstract][Full Text] [Related]
31. Transcriptosome and serum cytokine profiling of an atypical case of myelodysplastic syndrome with progression to acute myelogenous leukemia.
Mahadevan D; DiMento J; Croce KD; Riley C; George B; Fuchs D; Mathews T; Wilson C; Lobell M
Am J Hematol; 2006 Oct; 81(10):779-86. PubMed ID: 16838325
[TBL] [Abstract][Full Text] [Related]
32. Reversible differentiation of human monoblastic leukemia U937 cells by ML-9, an inhibitor of myosin light chain kinase.
Yamamoto-Yamaguchi Y; Makishima M; Kanatani Y; Kasukabe T; Honma Y
Exp Hematol; 1996 May; 24(6):682-9. PubMed ID: 8635523
[TBL] [Abstract][Full Text] [Related]
33. Human stem cell factor-antibody [anti-SCF] enhances chemotherapy cytotoxicity in human CD34+ resistant myeloid leukaemia cells.
Lu C; Hassan HT
Leuk Res; 2006 Mar; 30(3):296-302. PubMed ID: 16112192
[TBL] [Abstract][Full Text] [Related]
34. Expression of AML1 and ETO Transcripts in hematopoietic cells.
Era T; Asou N; Yamaguchi K; Yamasaki H; Kamada N; Nishikawa S; Takatsuki K
Leukemia; 1995 Oct; 9 Suppl 1():S26-8. PubMed ID: 7475308
[TBL] [Abstract][Full Text] [Related]
35. Prognostic Significance of the Lymphoblastic Leukemia-Derived Sequence 1 (LYL1) GeneExpression in Egyptian Patients with AcuteMyeloid Leukemia.
El-Menshawy N; Shahin D; Ghazi HF
Turk J Haematol; 2014 Jun; 31(2):128-35. PubMed ID: 25035669
[TBL] [Abstract][Full Text] [Related]
36. Suspected leukemia oncoproteins CREB1 and LYL1 regulate Op18/STMN1 expression.
San-Marina S; Han Y; Liu J; Minden MD
Biochim Biophys Acta; 2012; 1819(11-12):1164-72. PubMed ID: 23000483
[TBL] [Abstract][Full Text] [Related]
37. BP1, a new homeobox gene, is frequently expressed in acute leukemias.
Haga SB; Fu S; Karp JE; Ross DD; Williams DM; Hankins WD; Behm F; Ruscetti FW; Chang M; Smith BD; Becton D; Raimondi SC; Berg PE
Leukemia; 2000 Nov; 14(11):1867-75. PubMed ID: 11069021
[TBL] [Abstract][Full Text] [Related]
38. AHR signaling pathway reshapes the metabolism of AML/MDS cells and potentially leads to cytarabine resistance.
Jia Y; Guo J; Zhao Y; Zhang Z; Shi L; Fang Y; Wu D; Wu L; Chang C
Acta Biochim Biophys Sin (Shanghai); 2021 Mar; 53(4):492-500. PubMed ID: 33709099
[TBL] [Abstract][Full Text] [Related]
39. A novel role for
Chiu SK; Saw J; Huang Y; Sonderegger SE; Wong NC; Powell DR; Beck D; Pimanda JE; Tremblay CS; Curtis DJ
Development; 2018 Oct; 145(19):. PubMed ID: 30185409
[TBL] [Abstract][Full Text] [Related]
40. The expansion of T-cells and hematopoietic progenitors as a result of overexpression of the lymphoblastic leukemia gene, Lyl1 can support leukemia formation.
Lukov GL; Rossi L; Souroullas GP; Mao R; Goodell MA
Leuk Res; 2011 Mar; 35(3):405-12. PubMed ID: 20705338
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
